All Stories

  1. Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics

    Article • mAbs, December 2018, Taylor & Francis

    Dr David W Keizer, John Marino, Alfred Ross, Hamish Grant

  2. Heterologous recombinant expression of non-originator NISTmAb

    Article • mAbs, June 2018, Taylor & Francis

    John Marino